The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infrants

A. Pellicer; G Greisen; M.J.N.L. Benders; O. Claris; E. Dempsey; M. Fumagalli; C. Gluud; C. Hagmann; L Hellstrom-Westas; S Hyttel-Sorensen; P.M.A. Lemmers; G. Naulaers; G Pichler; C Roll; F. van Bel; W. van Oeveren; M Skoog; M. Wolf; T. Austin

The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infrants

Translated title of the contribution: The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infrants

A. Pellicer
, G Greisen
, M.J.N.L. Benders
, O. Claris
, E. Dempsey
, M. Fumagalli
, C. Gluud
, C. Hagmann
, L Hellstrom-Westas
, S Hyttel-Sorensen
, P.M.A. Lemmers
, G. Naulaers
, G Pichler
, C Roll
, F. van Bel
, W. van Oeveren
, M Skoog
, M. Wolf
, T. Austin

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infrants
Original language	Undefined/Unknown
Pages (from-to)	171-178
Number of pages	8
Journal	Neonatology
Volume	104
Issue number	3
Publication status	Published - 2013

Keywords

Econometric and Statistical Methods: General
Geneeskunde (GENK)
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid

Cite this

Pellicer, A., Greisen, G., Benders, M. J. N. L., Claris, O., Dempsey, E., Fumagalli, M., Gluud, C., Hagmann, C., Hellstrom-Westas, L., Hyttel-Sorensen, S., Lemmers, P. M. A., Naulaers, G., Pichler, G., Roll, C., van Bel, F., van Oeveren, W., Skoog, M., Wolf, M., & Austin, T. (2013). The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infrants. Neonatology, 104(3), 171-178.

@article{62d746ecf4a645d5ac79925c3d9c5638,

title = "The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infrants",

keywords = "Econometric and Statistical Methods: General, Geneeskunde (GENK), Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid",

author = "A. Pellicer and G Greisen and M.J.N.L. Benders and O. Claris and E. Dempsey and M. Fumagalli and C. Gluud and C. Hagmann and L Hellstrom-Westas and S Hyttel-Sorensen and P.M.A. Lemmers and G. Naulaers and G Pichler and C Roll and \{van Bel\}, F. and \{van Oeveren\}, W. and M Skoog and M. Wolf and T. Austin",

year = "2013",

language = "Undefined/Unknown",

volume = "104",

pages = "171--178",

journal = "Neonatology",

issn = "1661-7800",

publisher = "S. Karger AG",

number = "3",

}

Pellicer, A, Greisen, G, Benders, MJNL, Claris, O, Dempsey, E, Fumagalli, M, Gluud, C, Hagmann, C, Hellstrom-Westas, L, Hyttel-Sorensen, S, Lemmers, PMA, Naulaers, G, Pichler, G, Roll, C, van Bel, F, van Oeveren, W, Skoog, M, Wolf, M & Austin, T 2013, 'The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infrants', Neonatology, vol. 104, no. 3, pp. 171-178.

The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infrants. / Pellicer, A.; Greisen, G; Benders, M.J.N.L. et al.
In: Neonatology, Vol. 104, No. 3, 2013, p. 171-178.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infrants

AU - Pellicer, A.

AU - Greisen, G

AU - Benders, M.J.N.L.

AU - Claris, O.

AU - Dempsey, E.

AU - Fumagalli, M.

AU - Gluud, C.

AU - Hagmann, C.

AU - Hellstrom-Westas, L

AU - Hyttel-Sorensen, S

AU - Lemmers, P.M.A.

AU - Naulaers, G.

AU - Pichler, G

AU - Roll, C

AU - van Bel, F.

AU - van Oeveren, W.

AU - Skoog, M

AU - Wolf, M.

AU - Austin, T.

PY - 2013

Y1 - 2013

KW - Econometric and Statistical Methods: General

KW - Geneeskunde (GENK)

KW - Geneeskunde(GENK)

KW - Medical sciences

KW - Bescherming en bevordering van de menselijke gezondheid

M3 - Article

SN - 1661-7800

VL - 104

SP - 171

EP - 178

JO - Neonatology

JF - Neonatology

IS - 3

ER -